We recommend using a newer internet browser, such as Google Chrome or Microsoft Edge, to optimize your browsing experience.

Skip to main content

Open-Label Study of the Pharmacokinetics of Omacetaxine Mepesuccinate

- Hematologic Malignancies | Solid Tumors
- Completed

Study Title: An Open-Label Study to Investigate the Pharmacokinetics of Omacetaxine Mepesuccinate

Teva Identifier: C41443/1103 Study | 2012-004003-12

ClinicalTrials.gov Identifier: NCT01844869

Study Status: Completed

Trial Condition(s): Hematologic Malignancies | Solid Tumors

Interventions: Drug: omacetaxine mepesuccinate

Study Description: Please refer to ClinicalTrials.gov for a description of the trial

Click for participation criteria and map of study locations

cancer icon for clinical trials

Key Participation Requirements

Gender: Female, Male

Age Range: 18 Years and older

Trial Duration: 07/01/2013 - 01/01/2015

Phase: Phase 1

Study Type

Interventional